On February 2, 2016, Mark Tengler notified Neos Therapeutics, Inc. of his resignation as Chief Technology Officer of the Company. Mr. Tengler's resignation is effective as of March 1, 2016.
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |